Main content
Academic [amp] Industry Intersection Conference explores Georgia as a biotechnology capital

Media Contact

Holly Korschun

The Seventh Annual Academic & Industry Intersection Conference: Georgia as a Biotechnology Capital? will explore the challenges, successes and future horizons of Georgia’s journey to national leadership in biotechnology.

The event takes place April 14, 2016, from 9 a.m. until 1:30 p.m. at the Emory Conference Center Hotel, Starvine Ballroom, 1615 Clifton Rd., NE, Atlanta, GA 30329.

The conference includes keynote addresses by C. Michael Cassidy, president and CEO of the Georgia Research Alliance, and Kenneth I. Moch, managing partner, Salutramed Group.

Michael Cassidy will provide a local state-of-affairs view of Georgia’s biotechnology past, present and future to begin open dialogue and motivate change. As the leader of GRA for 16 years, he will deliver clear insight on the state’s journey as a biotechnology capital, while sharing his vision for the state, celebrating our strengths and defining our weaknesses. His experience and understanding of city and state politics will resonate and enlighten the expert audience.

Kenneth Moch will offer a regional and national perspective and discuss the current and future biotechnology climate. He will share best practices and advice for Georgia to become a biotechnology capital using his broad expertise building, managing and financing private and public life sciences companies from start-up through commercialization, and creation of five companies that have pioneered novel technologies.

In addition, two conference panels will include Entrepreneurial Training Programs in Georgia and Local and National Investor Perspectives.

The Atlanta Clinical & Translational Science Institute (ACTSI), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state’s life sciences industry association, organize this conference annually. This year’s conference will explore Georgia’s biotechnology climate and venture capital innovation, and will feature an expert panel highlighting commercialization training options throughout the state.

Registration is available here.

For more information, contact Elizabeth Thompson,, 404-727-2579

Recent News